Correlation Between Quest PharmaTech and CytomX Therapeutics
Can any of the company-specific risk be diversified away by investing in both Quest PharmaTech and CytomX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quest PharmaTech and CytomX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quest PharmaTech and CytomX Therapeutics, you can compare the effects of market volatilities on Quest PharmaTech and CytomX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quest PharmaTech with a short position of CytomX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quest PharmaTech and CytomX Therapeutics.
Diversification Opportunities for Quest PharmaTech and CytomX Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Quest and CytomX is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Quest PharmaTech and CytomX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CytomX Therapeutics and Quest PharmaTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quest PharmaTech are associated (or correlated) with CytomX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CytomX Therapeutics has no effect on the direction of Quest PharmaTech i.e., Quest PharmaTech and CytomX Therapeutics go up and down completely randomly.
Pair Corralation between Quest PharmaTech and CytomX Therapeutics
Assuming the 90 days horizon Quest PharmaTech is expected to under-perform the CytomX Therapeutics. But the pink sheet apears to be less risky and, when comparing its historical volatility, Quest PharmaTech is 3.07 times less risky than CytomX Therapeutics. The pink sheet trades about -0.07 of its potential returns per unit of risk. The CytomX Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 145.00 in CytomX Therapeutics on September 14, 2024 and sell it today you would lose (37.00) from holding CytomX Therapeutics or give up 25.52% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Quest PharmaTech vs. CytomX Therapeutics
Performance |
| Timeline |
| Quest PharmaTech |
| CytomX Therapeutics |
Quest PharmaTech and CytomX Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Quest PharmaTech and CytomX Therapeutics
The main advantage of trading using opposite Quest PharmaTech and CytomX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quest PharmaTech position performs unexpectedly, CytomX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CytomX Therapeutics will offset losses from the drop in CytomX Therapeutics' long position.| Quest PharmaTech vs. Coya Therapeutics, Common | Quest PharmaTech vs. Cue Biopharma | Quest PharmaTech vs. Lantern Pharma | Quest PharmaTech vs. Fennec Pharmaceuticals |
| CytomX Therapeutics vs. Puma Biotechnology | CytomX Therapeutics vs. Iovance Biotherapeutics | CytomX Therapeutics vs. Day One Biopharmaceuticals | CytomX Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |